These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6753109)

  • 1. Effect of silymarin on chemical, functional, and morphological alterations of the liver. A double-blind controlled study.
    Salmi HA; Sarna S
    Scand J Gastroenterol; 1982 Jun; 17(4):517-21. PubMed ID: 6753109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Liverubin™ on hepatic biochemical profile in patients of alcoholic liver disease: a retrospective study.
    Nanda V; Gupta V; Sharma SN; Pasricha A; Karmakar AK; Patel A; Bhatt VM; Kantroo BL; Kumar B; Paul NK; Attam R
    Minerva Med; 2014 Dec; 105(6 Suppl 2):1-8. PubMed ID: 26076375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Liver-protective action of silymarin therapy in chronic alcoholic liver diseases].
    Fehér J; Deák G; Müzes G; Láng I; Niederland V; Nékám K; Kárteszi M
    Orv Hetil; 1989 Dec; 130(51):2723-7. PubMed ID: 2574842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of a double blind study on the effect of silymarin in the treatment of acute viral hepatitis, carried out at two medical centres (author's transl)].
    Magliulo E; Gagliardi B; Fiori GP
    Med Klin; 1978 Jul; 73(28-29):1060-5. PubMed ID: 353464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Silymarin for the treatment of acute viral hepatitis? Report of a controlled trial (author's transl)].
    Bode JC; Schmidt U; Dürr HK
    Med Klin; 1977 Mar; 72(12):513-8. PubMed ID: 840125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of acute virus hepatitis with silymarin. Report of a controlled study].
    Schmidt U; Dürr HK; Bode JC
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():563-5. PubMed ID: 25535
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical investigation of silymarin in chronic liver diseases (author's transl)].
    Realini S; Gonvers JJ; Hofstetter JR
    Schweiz Rundsch Med Prax; 1975 May; 64(19):595-8. PubMed ID: 51497
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunomodulator effect of silymarin therapy in chronic alcoholic liver diseases].
    Deák G; Müzes G; Láng I; Niederland V; Nékám K; Gonzalez-Cabello R; Gergely P; Fehér J
    Orv Hetil; 1990 Jun; 131(24):1291-2, 1295-6. PubMed ID: 2195425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Controlled study of the effect of silymarin on alcoholic liver disease].
    Bunout D; Hirsch S; Petermann M; de la Maza MP; Silva G; Kelly M; Ugarte G; Iturriaga H
    Rev Med Chil; 1992 Dec; 120(12):1370-5. PubMed ID: 1343377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liverubin (standardized silymarin) in the supplementary management of functional, temporary hepatic damage. A pilot, registry, study.
    Belcaro G; Hu S; Gizzi G; Corsi M; Dugall M; Hu S; Pellegrini L; Ledda A; Cornelli U; Cesarone MR; Hosoi M; Luzzi R
    Minerva Med; 2014 Dec; 105(6 Suppl 2):17-25. PubMed ID: 26076377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Increased transaminases--differential diagnosis and evaluation].
    Elke B; Battegay E; Müllhaupt B
    Praxis (Bern 1994); 2008 May; 97(11):587-96; quiz 596-7. PubMed ID: 18592953
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of silymarin on biochemical indicators in patients with liver disease: Systematic review with meta-analysis.
    de Avelar CR; Pereira EM; de Farias Costa PR; de Jesus RP; de Oliveira LPM
    World J Gastroenterol; 2017 Jul; 23(27):5004-5017. PubMed ID: 28785154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Silymarin action in liver diseases].
    Hammerl H; Pichler O; Studlar M
    Med Klin; 1971 Sep; 66(36):1204-8. PubMed ID: 5096207
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunomodulatory and hepatoprotective effects of in vivo treatment with free radical scavengers.
    Láng I; Nékám K; Deák G; Müzes G; Gonzales-Cabello R; Gergely P; Csomós G; Fehér J
    Ital J Gastroenterol; 1990 Oct; 22(5):283-7. PubMed ID: 1983711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated serum liver enzymes in obesity: a dilemma during clinical trials.
    Golik A; Rubio A; Weintraub M; Byrne L
    Int J Obes; 1991 Dec; 15(12):797-801. PubMed ID: 1794921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of silymarin on rat liver injury induced by ischemia.
    Wu CG; Chamuleau RA; Bosch KS; Frederiks WM
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 64(5):259-63. PubMed ID: 8287122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver.
    Ferenci P; Dragosics B; Dittrich H; Frank H; Benda L; Lochs H; Meryn S; Base W; Schneider B
    J Hepatol; 1989 Jul; 9(1):105-13. PubMed ID: 2671116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment options for nonalcoholic fatty liver disease: a double-blinded randomized placebo-controlled trial.
    Anushiravani A; Haddadi N; Pourfarmanbar M; Mohammadkarimi V
    Eur J Gastroenterol Hepatol; 2019 May; 31(5):613-617. PubMed ID: 30920975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Milk thistle (Silybum marianum) derivatives in the therapy of chronic hepatopathies].
    De Martiis M; Fontana M; Assogna G; D'Ottavi R; D'Ottavi O
    Clin Ter; 1980 Aug; 94(3):283-315. PubMed ID: 7004762
    [No Abstract]   [Full Text] [Related]  

  • 20. Protective effect of cordycepin-enriched Cordyceps militaris on alcoholic hepatotoxicity in Sprague-Dawley rats.
    Cha JY; Ahn HY; Cho YS; Je JY
    Food Chem Toxicol; 2013 Oct; 60():52-7. PubMed ID: 23876821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.